No abstract available
MeSH terms
-
Animals
-
CRISPR-Cas Systems / genetics*
-
Carcinoma, Non-Small-Cell Lung / immunology*
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
China
-
Clinical Trials, Phase I as Topic*
-
Embryo Research
-
Gene Knockout Techniques
-
Genetic Engineering*
-
HIV Infections / therapy
-
Haplorhini / genetics
-
Humans
-
Immunotherapy / methods
-
Lung Neoplasms / immunology*
-
Lung Neoplasms / therapy*
-
National Institutes of Health (U.S.)
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Programmed Cell Death 1 Receptor / deficiency
-
Programmed Cell Death 1 Receptor / genetics
-
Programmed Cell Death 1 Receptor / immunology
-
Reproducibility of Results
-
T-Lymphocytes / immunology
-
T-Lymphocytes / metabolism
-
United States
-
United States Food and Drug Administration
Substances
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor